Literature DB >> 17426926

Alterations in expression of senescence marker protein-30 gene by 3,3',5-triiodo-L-thyronine (T3).

Pranati Sar1, Bandita Rath, Umakanta Subudhi, Gagan Bihari Nityananda Chainy, Prakash Chandra Supakar.   

Abstract

Thyroid hormone (T3) is essential for normal development, differentiation, and metabolic balance of the body. A toxic dose of T(3) in animals increases the basal metabolic rate and reactive oxygen species production, resulting more oxidative stress through Ca(2+) influx to cytoplasm. Senescence Marker Protein-30 (SMP30) is preferentially expressed in the liver and protects cells against various injuries by enhancement of Ca(2+) efflux to either extra cellular space or intraorganellar spaces through membrane Ca(2+) pump activity. In this paper we report an alteration in the level of SMP30 gene expression using RT-PCR and western blot analysis in T(3) treated female Wistar rats. The results indicate that there is an induction of SMP30 expression during early hours of T(3 )treatment and it declines in severe hyperthyroidism. Therefore, we speculate that SMP30 is regulated by T(3) and might play a protective role in hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17426926     DOI: 10.1007/s11010-007-9462-1

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.842


  27 in total

Review 1.  Energy metabolism, thyroid calorigenesis, and oxidative stress: functional and cytotoxic consequences.

Authors:  L A Videla
Journal:  Redox Rep       Date:  2000       Impact factor: 4.412

2.  Two thyroid hormone-mediated gene expression patterns in vivo identified by cDNA expression arrays in rat.

Authors:  J M Weitzel; C Radtke; H J Seitz
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

3.  Clinical significance of risedronate for osteoporosis in the initial treatment of male patients with Graves' disease.

Authors:  Takafumi Majima; Yasato Komatsu; Kentaro Doi; Chieko Takagi; Michika Shigemoto; Atsushi Fukao; Takeshi Morimoto; Jerry Corners; Kazuwa Nakao
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

4.  Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation.

Authors:  K Brown; S Gerstberger; L Carlson; G Franzoso; U Siebenlist
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

5.  Patterns of liver gene expression governed by TRbeta.

Authors:  Amilcar Flores-Morales; Hjalmar Gullberg; Leandro Fernandez; Nina Ståhlberg; Norman H Lee; Björn Vennström; Gunnar Norstedt
Journal:  Mol Endocrinol       Date:  2002-06

6.  Nuclear localization of senescence marker protein-30, SMP30, in cultured mouse hepatocytes and its similarity to RNA polymerase.

Authors:  Akihito Ishigami; Setsuko Handa; Naoki Maruyama; Prakash C Supakar
Journal:  Biosci Biotechnol Biochem       Date:  2003-01       Impact factor: 2.043

7.  Hepatic gene expression patterns in thyroid hormone-treated hypothyroid rats.

Authors:  J M Weitzel; S Hamann; M Jauk; M Lacey; A Filbry; C Radtke; K A H Iwen; S Kutz; A Harneit; P M Lizardi; H J Seitz
Journal:  J Mol Endocrinol       Date:  2003-10       Impact factor: 5.098

8.  Differential effects of experimental and cold-induced hyperthyroidism on factors inducing rat liver oxidative damage.

Authors:  P Venditti; R Pamplona; V Ayala; R De Rosa; G Caldarone; S Di Meo
Journal:  J Exp Biol       Date:  2006-03       Impact factor: 3.312

9.  Gene regulation of senescence marker protein-30 (SMP30): coordinated up-regulation with tissue maturation and gradual down-regulation with aging.

Authors:  T Fujita; T Shirasawa; K Uchida; N Maruyama
Journal:  Mech Ageing Dev       Date:  1996-06-25       Impact factor: 5.432

10.  Senescence marker protein-30 (SMP30) rescues cell death by enhancing plasma membrane Ca(2+)-pumping activity in Hep G2 cells.

Authors:  T Fujita; H Inoue; T Kitamura; N Sato; T Shimosawa; N Maruyama
Journal:  Biochem Biophys Res Commun       Date:  1998-09-18       Impact factor: 3.575

View more
  7 in total

1.  ENA-A actimineral resource A extends lifespan associated with antioxidant mechanism in SMP30 knockout mice.

Authors:  Jung-Youn Han; Meeyul Hwang; Sung-Yong Hwa; Jin-Kyu Park; Mi-Ran Ki; Il-Hwa Hong; Ah-Young Kim; Eun-Mi Lee; Eun-Joo Lee; Chang-Woo Min; Kyung-Ku Kang; Myeong-Mi Lee; Soo-Eun Sung; Kyu-Shik Jeong
Journal:  Mol Cell Biochem       Date:  2014-03-07       Impact factor: 3.396

Review 2.  From the stomach to other organs: Helicobacter pylori and the liver.

Authors:  Marek Waluga; Michał Kukla; Michał Żorniak; Agata Bacik; Rafał Kotulski
Journal:  World J Hepatol       Date:  2015-08-28

Review 3.  The diverse roles of calcium-binding protein regucalcin in cell biology: from tissue expression and signalling to disease.

Authors:  Ricardo Marques; Cláudio J Maia; Cátia Vaz; Sara Correia; Sílvia Socorro
Journal:  Cell Mol Life Sci       Date:  2013-03-22       Impact factor: 9.261

4.  3, 3'5 Triiodo L thyronine induces apoptosis in human breast cancer MCF-7 cells, repressing SMP30 expression through negative thyroid response elements.

Authors:  Pranati Sar; Rosalima Peter; Bandita Rath; Alok Das Mohapatra; Sandip K Mishra
Journal:  PLoS One       Date:  2011-06-07       Impact factor: 3.240

5.  Molecular characterization of senescence marker protein-30 gene promoter: identification of repressor elements and functional nuclear factor binding sites.

Authors:  Bandita Rath; Ravi S Pandey; Priya R Debata; Naoki Maruyama; Prakash C Supakar
Journal:  BMC Mol Biol       Date:  2008-04-29       Impact factor: 2.946

6.  Regucalcin expression in bovine tissues and its regulation by sex steroid hormones in accessory sex glands.

Authors:  Laura Starvaggi Cucuzza; Sara Divari; Chiara Mulasso; Bartolomeo Biolatti; Francesca T Cannizzo
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

Review 7.  Prospective role of thyroid disorders in monitoring COVID-19 pandemic.

Authors:  Kanchan Kumari; Gagan B N Chainy; Umakanta Subudhi
Journal:  Heliyon       Date:  2020-12-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.